Table 1 Patient characteristics and perioperative data. Values are mean (SD) or numbers (proportion)
Sugammadex 1 + 1 mg/kg group n = 40 | Sugammadex 2 mg/kg group n = 40 | Neostigmine group n = 40 | |
|---|---|---|---|
Age; years | 46.6 (16.8) | 39.5 (14.5) | 44.9 (16.5) |
Male/Female; n | 13/27 | 24/16 | 20/20 |
BMI; kg.m−2 | 25.7 (5.7) | 26.1 (6.3) | 25.1 (6.1) |
ASA I/II/III; n | 22/14/4 | 23/15/2 | 20/17/3 |
Premorbid status | |||
Cough; n | |||
Acute < 2 weeks | 1 (2.5) | 0 | 0 |
Chronic | 0 | 2 (5.0) | 1 (2.5) |
No cough | 39 (97.5) | 38 (95.0) | 39 (97.5) |
Asthma; n | |||
Controlled | 1 (2.5) | 4 (10.0) | 1 (2.5) |
Uncontrolled | 0 | 0 | 0 |
Non-asthmatic | 39 (97.5) | 36 (90.0) | 39 (97.5) |
Smokers; n | |||
≥ 10 cigarettes/day | 3 (7.5) | 9 (22.5) | 6 (15.0) |
< 10 cigarettes/day | 1 (2.5) | 1 (2.5) | 2 (5.0) |
Ex-smoker | 3 (7.5) | 1 (2.5) | 4 (10.0) |
Never smoked | 33 (82.5) | 29 (72.5) | 28 (70.0) |
Operative data | |||
Types of surgery; n | |||
General surgery | 14 (35.0) | 11 (27.5) | 11 (27.5) |
Neurosurgery | 4 (10.0) | 3 (7.5) | 11 (27.5) |
Orthopedic | 6 (15.0) | 8 (20.0) | 5 (12.5) |
Gynecology | 13 (32.5) | 9 (36.0) | 3 (7.5) |
Ear, nose and throat | 0 | 2 (5.0) | 4 (10.0) |
Dental | 0 | 2 (5.0) | 0 |
Opthalmology | 1 (2.5) | 2 (5.0) | 0 |
Urology | 2 (5.0) | 3 (7.5) | 6 (15.0) |
Duration of surgery; n | |||
< 1 h | 0 | 2 (5.0) | 3 (7.5) |
1-4 h | 33 (82.5) | 32 (80.0) | 30 (75.0) |
> 4 h | 7 (17.5) | 6 (15.0) | 7 (17.5) |
Anesthesia time; min | 165.1 (73.7) | 162.2 (81.0) | 164.0 (86.7) |
Intubation; n | |||
Normal (CML I-II) | 36 (90.0) | 34 (85.0) | 36 (90.0) |
Difficult (CML III-IV) | 4 (10.0) | 6 (15.0) | 4 (10.0) |
Rocuronium; mg | 54.9 (18.1) | 56.9 (19.6) | 52.0 (15.3) |
Remifentanil; n | 4 (10.0) | 2 (5.9) | 9 (22.5) |
Inhalational agent; n | |||
Sevoflurane | 19 (47.5) | 18 (45.0) | 20 (50.0) |
Desflurane | 21 (52.5) | 21 (51.5) | 20 (50.0) |
None | 0 | 1 (2.5) | 0 |